Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
COSTS AND EXPENSES:    
Research and development $ 5,158,874 $ 5,964,453
General and administrative 3,395,360 3,704,676
Restructuring costs 203,631 221,816
Total costs and expenses 8,757,865 9,890,945
LOSS FROM OPERATIONS (8,757,865) (9,890,945)
OTHER INCOME (EXPENSE):    
Gain on revaluation of derivative warrants 3,667,826 2,285,157
Loss on issuance of derivative warrants (404,150) 0
Interest expense, net (841) (446,314)
Total other income, net 3,262,835 1,838,843
NET LOSS $ (5,495,030) $ (8,052,102)
BASIC AND DILUTED NET LOSS PER COMMON SHARE $ (7.03) $ (17.53)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE 781,975 459,266